Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors

Yasuhide Yamada, Tomohide Tamura, Noboru Yamamoto, Tatsu Shimoyama, Yutaka Ueda, Haruyasu Murakami, Hitoshi Kusaba, Yoshikazu Kamiya, Hideo Saka, Yusuke Tanigawara, J. Patrick McGovren, Yutaka Natsumeda

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds